BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 25862816)

  • 1. Polycomb Repressive Complex 2 Confers BRG1 Dependency on the CIITA Locus.
    Abou El Hassan M; Yu T; Song L; Bremner R
    J Immunol; 2015 May; 194(10):5007-13. PubMed ID: 25862816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon-gamma-induced chromatin remodeling at the CIITA locus is BRG1 dependent.
    Pattenden SG; Klose R; Karaskov E; Bremner R
    EMBO J; 2002 Apr; 21(8):1978-86. PubMed ID: 11953317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The chromatin-remodeling enzyme BRG1 coordinates CIITA induction through many interdependent distal enhancers.
    Ni Z; Abou El Hassan M; Xu Z; Yu T; Bremner R
    Nat Immunol; 2008 Jul; 9(7):785-93. PubMed ID: 18500344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polycomb recruitment at the Class II transactivator gene.
    Boyd NH; Morgan JE; Greer SF
    Mol Immunol; 2015 Oct; 67(2 Pt B):482-91. PubMed ID: 26283540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apical role for BRG1 in cytokine-induced promoter assembly.
    Ni Z; Karaskov E; Yu T; Callaghan SM; Der S; Park DS; Xu Z; Pattenden SG; Bremner R
    Proc Natl Acad Sci U S A; 2005 Oct; 102(41):14611-6. PubMed ID: 16195385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A role for EZH2 in silencing of IFN-gamma inducible MHC2TA transcription in uveal melanoma.
    Holling TM; Bergevoet MW; Wilson L; Van Eggermond MC; Schooten E; Steenbergen RD; Snijders PJ; Jager MJ; Van den Elsen PJ
    J Immunol; 2007 Oct; 179(8):5317-25. PubMed ID: 17911618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of the INI1 tumor suppressor does not impair the expression of multiple BRG1-dependent genes or the assembly of SWI/SNF enzymes.
    Doan DN; Veal TM; Yan Z; Wang W; Jones SN; Imbalzano AN
    Oncogene; 2004 Apr; 23(19):3462-73. PubMed ID: 14990991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon-γ resets muscle cell fate by stimulating the sequential recruitment of JARID2 and PRC2 to promoters to repress myogenesis.
    Londhe P; Davie JK
    Sci Signal; 2013 Dec; 6(305):ra107. PubMed ID: 24327761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mammalian chromatin remodeling complex SWI/SNF is essential for enhanced expression of the albumin gene during liver development.
    Inayoshi Y; Miyake K; Machida Y; Kaneoka H; Terajima M; Dohda T; Takahashi M; Iijima S
    J Biochem; 2006 Feb; 139(2):177-88. PubMed ID: 16452305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PRC2-mediated repression of SMARCA2 predicts EZH2 inhibitor activity in SWI/SNF mutant tumors.
    Januario T; Ye X; Bainer R; Alicke B; Smith T; Haley B; Modrusan Z; Gould S; Yauch RL
    Proc Natl Acad Sci U S A; 2017 Nov; 114(46):12249-12254. PubMed ID: 29087303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptional targets of the chromatin-remodelling factor SMARCA4/BRG1 in lung cancer cells.
    Medina PP; Carretero J; Ballestar E; Angulo B; Lopez-Rios F; Esteller M; Sanchez-Cespedes M
    Hum Mol Genet; 2005 Apr; 14(7):973-82. PubMed ID: 15731117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A synthetic lethality-based strategy to treat cancers harboring a genetic deficiency in the chromatin remodeling factor BRG1.
    Oike T; Ogiwara H; Tominaga Y; Ito K; Ando O; Tsuta K; Mizukami T; Shimada Y; Isomura H; Komachi M; Furuta K; Watanabe S; Nakano T; Yokota J; Kohno T
    Cancer Res; 2013 Sep; 73(17):5508-18. PubMed ID: 23872584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Collagen and major histocompatibility class II expression in mesenchymal cells from CIITA hypomorphic mice.
    Xu Y; McDonald J; Perloff E; Butticè G; Schreiber BM; Smith BD
    Mol Immunol; 2007 Mar; 44(7):1709-21. PubMed ID: 16982097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SWI/SNF-Brg1 regulates self-renewal and occupies core pluripotency-related genes in embryonic stem cells.
    Kidder BL; Palmer S; Knott JG
    Stem Cells; 2009 Feb; 27(2):317-28. PubMed ID: 19056910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant expression of SWI/SNF catalytic subunits BRG1/BRM is associated with tumor development and increased invasiveness in prostate cancers.
    Sun A; Tawfik O; Gayed B; Thrasher JB; Hoestje S; Li C; Li B
    Prostate; 2007 Feb; 67(2):203-13. PubMed ID: 17075831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SWI/SNF chromatin remodeling complex is critical for the expression of microphthalmia-associated transcription factor in melanoma cells.
    Vachtenheim J; Ondrusová L; Borovanský J
    Biochem Biophys Res Commun; 2010 Feb; 392(3):454-9. PubMed ID: 20083088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dysregulated recruitment of the histone methyltransferase EZH2 to the class II transactivator (CIITA) promoter IV in breast cancer cells.
    Truax AD; Thakkar M; Greer SF
    PLoS One; 2012; 7(4):e36013. PubMed ID: 22563434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mycobacterium tuberculosis 19-kDa lipoprotein inhibits IFN-gamma-induced chromatin remodeling of MHC2TA by TLR2 and MAPK signaling.
    Pennini ME; Pai RK; Schultz DC; Boom WH; Harding CV
    J Immunol; 2006 Apr; 176(7):4323-30. PubMed ID: 16547269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SWI/SNF chromatin-remodeling factors induce changes in DNA methylation to promote transcriptional activation.
    Banine F; Bartlett C; Gunawardena R; Muchardt C; Yaniv M; Knudsen ES; Weissman BE; Sherman LS
    Cancer Res; 2005 May; 65(9):3542-7. PubMed ID: 15867346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brg1-dependent epigenetic control of vascular smooth muscle cell proliferation by hydrogen sulfide.
    Li L; Liu D; Bu D; Chen S; Wu J; Tang C; Du J; Jin H
    Biochim Biophys Acta; 2013 Jun; 1833(6):1347-55. PubMed ID: 23499876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.